HGEN in EU Commission 10 Most Promising Treatments for COVID-19!European Commission’s independent experts selected Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-19!
CEO of Humanigen said today: "We look forward to continuing our discussions with colleagues at the European Medicines Agency to advance our efforts to submit a marketing authorization application for lenzilumab in COVID-19".
In the same list you can see Pfizer, Roche, Astra Zeneca and Eli Lilly! Humanigen is the smallest company.
Institutions loaded big on this dip of Humanigen, Inc. (HGEN), 132Mil in the last quarter!
On 8/23/2021 Morgan Stanley reported an increased ownership in HGEN by +1,884.6%!
Biggest shareholder is Blackrock with 3,037,693 shares worth $52.80Mil, which increased its position by +283.5% for a total ownership of 5.141% of Humanigen.
So Blackrock paid an average of 17.3usd per share!
The price of the stock is now 6.60usd!
H.C. Wainwright’s Joseph Pantginis rates HGEN a Buy along with a $28 price target and said the market overreacted on that selloff.
My price target is the 16.3usd resistance!
Humanigen
Humanigen $HGEN is ready for a breakoutThese past weeks we saw a lot of action regarding $HGEN - not that much pricewise, but more on a fundamental basis like the long awaited news about the date for the Emergency-Use-Authorization (EUA), identified as a key driver for demand and price action.
Humanigen intends to request the EUA by June 2021. Looking at the chart, the price did not react as much to the news, most likely because of anticipation, whether they will receive the EUA or not (I assume they will). Humanigen has done a great job fulfilling the prerequisites (published Phase 3 data looks promising) and they recently had a meeting with the FDA to clarify the scope (www.biospace.com).
Several rating companies have set the target at 40$, but looking at the chart and institutional interest there is clearly a bit more upwards potential than that. 30$ has been reached previously and with Blackrock increasing their position, as well as HGEN being the 5th largest holding in the XBI ETF a target of 60$, 86$ and 102$ is more likely.
The big companies have done a great job in increasing their position without moving the stock's price too much. Right now we have a tight trading range and 20$ is working as a light resistance. A shakeout also occured yesterday and it is possible that more might follow. These are quite normal, as big companies try to improve their position.
-This is no financial advice-
For transparency: I am invested in $HGEN with 1/10 of my account size. I always keep buffer cash and never go all in!
Humanigen ($HGEN) with a lot of potentialThe COVID-19 pandemic is holding the world, the economy and our health in a tight grip. So far Biontech/Pfizer have been successful with their vaccination, but as the virus mutates, it is unclear how effective the vaccination is. Many COVID-19 infected patients have to be hospitalized with a need for mechanical ventilation and that is where Humanigen plays a major role.
Humanigen reports positive Phase 3 topline results demonstrating that their drug under the name Lenzilumab™ improves survival without need for mechanical ventilation. These news are really huge and better yet: Humanigen has requested an Emergency-Use-Authorization (EUA) from the FDA.
Now looking at the price development of the share, there were some nice intraday profit taking (PT) opportunities, but the stock has actually a potential to grow much more.
Look at the trading range and monthly levels to set your PT levels. There was a nice retest of the support level (at 15$ and a bit below), which had provided and excellent opportunity to buy in cheap, but catching a falling knife takes a lot of practice (I rarely succeed myself, but I was lucky with this particular trade).
Have your PT goal in mind, because most of the times people lose money, because they become to greedy or don't cut losses (had to learn this the hard way myself :D).
Other than that, I am really optimistic on the upwards potential of this gem.
- This is no financial advice, so trade with care -
For transparency: I am invested in $HGEN with 1/3 of my stock portfolio and usually keep 2/3 for dollar cost averaging.
